166 related articles for article (PubMed ID: 3918348)
1. Phenotypic and functional characterization of human malignant T cells.
Harden EA; Haynes BF
Semin Hematol; 1985 Jan; 22(1):13-26. PubMed ID: 3918348
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody studies in B(non-T)-cell malignancies.
Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
[TBL] [Abstract][Full Text] [Related]
3. Immunologic characterization of T-lymphoproliferative disorders by monoclonal antibodies.
Koubek K; Hrodek O; Starý J; Chudomel V; Malasková V
Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(5):649-57. PubMed ID: 2416641
[TBL] [Abstract][Full Text] [Related]
4. Human T cell differentiation antigens and correlation of their expression with various markers of T cell maturation.
Boumsell L; Bernard A; Coppin H; Richard Y; Penit C; Rouget P; Lemerle J; Dausset J
J Immunol; 1979 Nov; 123(5):2063-7. PubMed ID: 90700
[TBL] [Abstract][Full Text] [Related]
5. Human T cell antigens defined by monoclonal antibodies: the 65,000-dalton antigen of T cells (T65) is also found on chronic lymphocytic leukemia cells bearing surface immunoglobulin.
Royston I; Majda JA; Baird SM; Meserve BL; Griffiths JC
J Immunol; 1980 Aug; 125(2):725-31. PubMed ID: 6993560
[TBL] [Abstract][Full Text] [Related]
6. [Immunologic cell markers in lymphoproliferative diseases].
Samoĭlova RS
Ter Arkh; 1980; 52(9):140-9. PubMed ID: 7001662
[No Abstract] [Full Text] [Related]
7. Preparation and characterization of monoclonal antibodies recognizing three distinct differentiation antigens (BL1, BL2, BL3) on human B lymphocytes.
Wang CY; Azzo W; Al-Katib A; Chiorazzi N; Knowles DM
J Immunol; 1984 Aug; 133(2):684-91. PubMed ID: 6429242
[TBL] [Abstract][Full Text] [Related]
8. Leukemias and lymphomas of thymic differentiation.
Borowitz MJ; Falletta JM
Clin Lab Med; 1988 Mar; 8(1):119-34. PubMed ID: 2896085
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody against a membrane antigen characterizing leukemic human B-lymphocytes.
Forster HK; Gudat FG; Girard MF; Albrecht R; Schmidt J; Ludwig C; Obrecht JP
Cancer Res; 1982 May; 42(5):1927-34. PubMed ID: 6175400
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic diversity of T cell leukemias.
Greaves MF
J Clin Immunol; 1982 Jul; 2(3 Suppl):75S-80S. PubMed ID: 6982279
[TBL] [Abstract][Full Text] [Related]
11. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
[TBL] [Abstract][Full Text] [Related]
12. An unusual variant of T-CLL: evidence for the existence of a hitherto unrecognized T cell subset.
Moss VE; Miedema F; Matutes E; Terpstra F; Brownell A; Brozovic M; Catovsky D
Clin Exp Immunol; 1986 Feb; 63(2):303-11. PubMed ID: 3486061
[TBL] [Abstract][Full Text] [Related]
13. The application of monoclonal antibodies to the characterization and diagnosis of lymphoid neoplasms: a review of recent studies.
Knowles DM; Dodson LD; Raab R; Mittler RS; Talle MA; Goldstein G
Diagn Immunol; 1983; 1(3):142-9. PubMed ID: 6333955
[TBL] [Abstract][Full Text] [Related]
14. Detection of T and B cell populations in some lymphoproliferative disorders.
Herzog P; Stöckbauer P
Czech Med; 1980; 3(4):263-70. PubMed ID: 6971744
[TBL] [Abstract][Full Text] [Related]
15. T-lymphocyte malignancies: recent advances in the understanding of their biology, diagnosis and treatment.
Parkinson DR; Mier JW
Clin Immunol Rev; 1983; 2(1):59-121. PubMed ID: 6349892
[No Abstract] [Full Text] [Related]
16. [Surface marker studies on lymphoma and leukemia cells with microcytotoxicity test using the UCLA Monoclonal Antibody Tray 5].
Toki H; Okabe K; Kimura Y; Fujii M; Tamai M; Moriwaki S; Yamamoto Y
Gan No Rinsho; 1985 Apr; 31(4):409-13. PubMed ID: 3874297
[TBL] [Abstract][Full Text] [Related]
17. Exploitation of monoclonal antibodies: a "who's who" of haemopoietic malignancy.
Greaves MF; Delia D; Robinson J; Sutherland R; Newman R
Blood Cells; 1981; 7(2):257-80. PubMed ID: 7028183
[TBL] [Abstract][Full Text] [Related]
18. Atypical adult T-cell leukemia-lymphoma: diverse clinical manifestations of adult T-cell leukemia-lymphoma.
Shimoyama M; Minato K; Tobinai K; Nagai M; Setoya T; Takenaka T; Ishihara K; Watanabe S; Hoshino H; Miwa M; Kinoshita M; Okabe S; Fukushima N; Inada N
Jpn J Clin Oncol; 1983; 13 Suppl 2():165-87. PubMed ID: 6603526
[TBL] [Abstract][Full Text] [Related]
19. Anti-ATLA (antibody to adult T-cell leukemia virus-associated antigen), highly positive in OKT4-positive mature T-cell malignancies.
Tobinai K; Nagai M; Setoya T; Shibata T; Minato K; Shimoyama M
Jpn J Clin Oncol; 1983; 13 Suppl 2():237-44. PubMed ID: 6603532
[TBL] [Abstract][Full Text] [Related]
20. A report of a case of T-cell-derived chronic lymphocytic leukemia with antibodies to adult T-cell leukemia-associated antigens.
Utsunomiya A; Matsumoto M; Matsumoto T; Nishioka K; Iwahashi M; Hanada S; Nomura K; Hashimoto S; Yunoki K
Jpn J Clin Oncol; 1983; 13 Suppl 2():291-9. PubMed ID: 6603537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
